Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient

J Dermatol. 2019 Oct;46(10):e356-e357. doi: 10.1111/1346-8138.14905. Epub 2019 May 3.

Authors

Yuri Ishiguro¹, Yoshinao Muro¹, Chiaki Murase¹, Takuya Takeichi¹, Michihiro Kono¹, Runa Adachi², Kazuomi Takahashi³, Masashi Akiyama¹

Affiliations

¹ Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Department of Dermatology, Tosei General Hospital, Seto, Japan.
³ Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

PMID: 31050015
DOI: 10.1111/1346-8138.14905

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Cutaneous
Administration, Oral
Aged
Betamethasone / administration & dosage
Chilblains / drug therapy*
Drug Therapy, Combination / adverse effects
Drug Therapy, Combination / methods
Eosinophils
Erythema / blood
Erythema / chemically induced*
Erythema / diagnosis
Erythema / drug therapy
Female
Humans
Hydroxychloroquine / administration & dosage
Hydroxychloroquine / adverse effects*
Leukocyte Count
Lung / diagnostic imaging
Lupus Erythematosus, Cutaneous / drug therapy*
Prednisolone / therapeutic use
Pulmonary Eosinophilia / blood
Pulmonary Eosinophilia / chemically induced*
Pulmonary Eosinophilia / diagnosis
Pulmonary Eosinophilia / drug therapy
Skin / drug effects
Skin / pathology
Tomography, X-Ray Computed
Treatment Outcome

Substances

Hydroxychloroquine
Betamethasone
Prednisolone

Supplementary concepts

Chilblain lupus 1